VAISHALI PHARMA
Back to Balance Sheet
|
VAISHALI PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.18 Cr | ₹-0.18 Cr | ₹-0.14 Cr | ₹-0.16 Cr | ₹-0.15 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VAISHALI PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.18 Cr |
| Mar2024 | ₹-0.18 Cr |
| Mar2023 | ₹-0.14 Cr |
| Mar2022 | ₹-0.16 Cr |
| Mar2021 | ₹-0.15 Cr |
How is Deferred Tax Assets / Liabilities of VAISHALI PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.18 Cr | Negative | |
| Mar2024 | ₹-0.18 Cr | Negative | |
| Mar2023 | ₹-0.14 Cr | Negative | |
| Mar2022 | ₹-0.16 Cr | Negative | |
| Mar2021 | ₹-0.15 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of VAISHALI PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VAISHALI PHARMA | ₹104.0 Cr | -4.4% | -10.6% | -43.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹382,694.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,721.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,016.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹106,946.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,691.0 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
VAISHALI PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | -4.4% |
-10.6% |
-43.4% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses